BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22855598)

  • 21. Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas.
    Feldman AL; Law M; Remstein ED; Macon WR; Erickson LA; Grogg KL; Kurtin PJ; Dogan A
    Leukemia; 2009 Mar; 23(3):574-80. PubMed ID: 18987657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of WW domain-containing oxidoreductase WOX1 preferentially induces apoptosis in human glioblastoma cells harboring mutant p53.
    Chiang MF; Yeh ST; Liao HF; Chang NS; Chen YJ
    Biomed Pharmacother; 2012 Sep; 66(6):433-8. PubMed ID: 22898080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
    Zhang P; Zhang M
    Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequent disruption of the RB1 pathway in diffuse large B cell lymphoma: prognostic significance of E2F-1 and p16INK4A.
    Møller MB; Kania PW; Ino Y; Gerdes AM; Nielsen O; Louis DN; Skjødt K; Pedersen NT
    Leukemia; 2000 May; 14(5):898-904. PubMed ID: 10803523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    Chari NS; Ivan C; Le X; Li J; Mijiti A; Patel AA; Osman AA; Peterson CB; Williams MD; Pickering CR; Caulin C; Myers JN; Calin GA; Lai SY
    J Natl Cancer Inst; 2020 Mar; 112(3):266-277. PubMed ID: 31124563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
    Mélard P; Idrissi Y; Andrique L; Poglio S; Prochazkova-Carlotti M; Berhouet S; Boucher C; Laharanne E; Chevret E; Pham-Ledard A; De Souza Góes AC; Guyonnet-Duperat V; Bibeyran A; Moreau-Gaudry F; Vergier B; Beylot-Barry M; Merlio JP; Cappellen D
    Oncotarget; 2016 Oct; 7(42):68734-68748. PubMed ID: 27626696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.
    Peterson JF; Pearce KE; Meyer RG; Greipp PT; Knudson RA; Baughn LB; Ketterling RP; Feldman AL
    Histopathology; 2020 Feb; 76(3):481-485. PubMed ID: 31557339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.
    Streubel B; Vinatzer U; Willheim M; Raderer M; Chott A
    Leukemia; 2006 Feb; 20(2):313-8. PubMed ID: 16341044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Pathogenesis of Peripheral T Cell Lymphoma.
    Sakata-Yanagimoto M; Chiba S
    Curr Hematol Malig Rep; 2015 Dec; 10(4):429-37. PubMed ID: 26431836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma.
    Monti S; Chapuy B; Takeyama K; Rodig SJ; Hao Y; Yeda KT; Inguilizian H; Mermel C; Currie T; Dogan A; Kutok JL; Beroukhim R; Neuberg D; Habermann TM; Getz G; Kung AL; Golub TR; Shipp MA
    Cancer Cell; 2012 Sep; 22(3):359-72. PubMed ID: 22975378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences.
    Monti P; Russo D; Bocciardi R; Foggetti G; Menichini P; Divizia MT; Lerone M; Graziano C; Wischmeijer A; Viadiu H; Ravazzolo R; Inga A; Fronza G
    Hum Mutat; 2013 Jun; 34(6):894-904. PubMed ID: 23463580
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Maura F; Dodero A; Carniti C; Bolli N; Magni M; Monti V; Cabras A; Leongamornlert D; Abascal F; Diamond B; Rodriguez-Martin B; Zamora J; Butler A; Martincorena I; Tubio JMC; Campbell PJ; Chiappella A; Pruneri G; Corradini P
    Haematologica; 2021 Nov; 106(11):2918-2926. PubMed ID: 33054126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 expression in large B-cell lymphomas with MYC extra copies and CD99 expression in large B-cell lymphomas in relation to MYC status.
    Richardson AI; Zhang D; Woodroof J; Cui W
    Hum Pathol; 2019 Apr; 86():21-31. PubMed ID: 30496802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas.
    Marquard L; Poulsen CB; Gjerdrum LM; de Nully Brown P; Christensen IJ; Jensen PB; Sehested M; Johansen P; Ralfkiaer E
    Histopathology; 2009 May; 54(6):688-98. PubMed ID: 19438744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression.
    Huang HS; Liao CK; Liu TT; You HL; Wang MC; Huang WT
    Hum Pathol; 2018 Oct; 80():145-151. PubMed ID: 29885407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
    Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
    Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.